Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey

Authors: Nathan J. Kolla, Mark van der Maas, Maggie E. Toplak, Patricia G. Erickson, Robert E. Mann, Jane Seeley, Evelyn Vingilis

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

Adult attention deficit hyperactivity disorder (ADHD) shows a robust association with alcohol and cannabis misuse, and these relationships are expressed differently in males and females. Manifestation of specific ADHD symptom profiles, even in the absence of the full disorder, may also be related to problems with alcohol and cannabis, although these relationships have not been investigated in epidemiological studies. To address this question, we studied the sex-specific associations of ADHD symptomatology with problematic alcohol and cannabis use in a representative sample of adults aged 18 years and older residing in Ontario, Canada.

Methods

Data were obtained from the Centre for Addiction and Mental Health Monitor, an ongoing cross-sectional telephone survey, between January 2011 and December 2013. Respondents (n = 5080) reported on current ADHD symptomatology, measured using the Adult ADHD Self-Report Version 1.1 Screener (ASRS-V1.1) and four additional items, and alcohol and cannabis use, which were measured using the Alcohol Use Disorders Identification Test (AUDIT) and the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), respectively. Logistic regression analyses were conducted in men and women to test the association of each ADHD symptom cluster (hyperactivity, inattentiveness, impulsivity) with problematic alcohol and cannabis use.

Results

After controlling for age, education, and comorbid internalizing and externalizing psychopathology, hyperactive symptoms were associated with problematic alcohol use in both men and women and with problematic cannabis use in men. Impulsive symptoms were independently associated with problematic cannabis use in men. By contrast, inattentive symptomatology predicted problems with alcohol and cannabis only in women. In all models, age was negatively associated with substance misuse and externalizing behavior was positively correlated and the strongest predictor of hazardous alcohol and cannabis use.

Conclusions

ADHD symptom expression in adulthood is related to concurrent hazardous use of alcohol and cannabis. Distinctive ADHD symptom profiles may confer increased risk for substance misuse in a sex-specific manner.
Literature
1.
SAMHSA. Results from the 2011 national survey on drug use and health: national findings. Rockville: US Government Printing Office; 2011.
2.
Charach A, Yeung E, Climans T, Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad of Child Adolesc Psychiatry. 2011;50(1):9–21.CrossRef
3.
Estevez N, Dey M, Eich-Hochli D, Foster S, Gmel G, Mohler-Kuo M. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men. Epidemiol Psychiatr Sci. 2015;1–12.
4.
Davis C, Cohen A, Davids M, Rabindranath A. Attention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex. Front psychiatry. 2015;6:47.PubMedCentralCrossRefPubMed
5.
Bidwell LC, Henry EA, Willcutt EG, Kinnear MK, Ito TA. Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students. Drug Alcohol Depen. 2014;135:88–94.CrossRef
6.
Upadhyaya HP, Carpenter MJ. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addiction. 2008;17(3):195–8.CrossRef
7.
De Alwis D, Lynskey MT, Reiersen AM, Agrawal A. Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addict Behav. 2014;39(8):1278–85.PubMedCentralCrossRefPubMed
8.
Kessler RC, Avenevoli S, McLaughlin KA, Green JG, Lakoma MD, Petukhova M, et al. Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Med. 2012;42(9):1997–2010.PubMedCentralCrossRefPubMed
9.
Glantz MD, Anthony JC, Berglund PA, Degenhardt L, Dierker L, Kalaydjian A, et al. Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med. 2009;39(8):1365–77.PubMedCentralCrossRefPubMed
10.
Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012;42(4):875–87.PubMedCentralCrossRefPubMed
11.
Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. Addict Behav. 2014;39(1):325–8.CrossRefPubMed
12.
Vingilis E, Mann RE, Erickson P, Toplak M, Kolla NJ, Seeley J, et al. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample. Traffic Inj Prev. 2014;15 Suppl 1:S1–9.CrossRefPubMed
13.
Ialomiteanu A, Adlaf EM. CAMH monitor 2011: metadata user’s guide. Toronto: Centre for Addiction and Mental Health; 2012.
14.
Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–56.CrossRefPubMed
15.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington: American Psychiatric Association; 1994.
16.
Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52–65.PubMedCentralCrossRefPubMed
17.
Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, et al. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145–8.CrossRefPubMed
18.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
19.
Sorge GB, Flora DB, van der Maas M, Vingilis E, Erickson P, Kolla NJ, et al. Using factor analytic models to examine the association between attention-deficit/hyperactivity disorder symptoms and health-related outcomes in a representative population survey. Atten Defic Hyperact Disord. 2015;7(3):225–35.CrossRefPubMed
20.
Cronbach LJ. Coefficient Alpha and the Internal Structure of Tests. Psychometrika. 1951;16(3):297–334.CrossRef
21.
Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26.CrossRefPubMed
22.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction. 1993;88(6):791–804.CrossRefPubMed
23.
Kirst M, Mecredy G, Chaiton M. The prevalence of tobacco use co-morbidities in Canada. Can J Public Health. 2013;104(3):e210–5.PubMed
24.
Mann RE, Stoduto G, Vingilis E, Asbridge M, Wickens CM, Ialomiteanu A, et al. Alcohol and driving factors in collision risk. Accident Anal Prev. 2010;42(6):1538–44.CrossRef
25.
Group WAW. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef
26.
Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiat. 2004;65 Suppl 3:27–37.
27.
Campbell A, Walker J, Farrell G. Confirmatory factor analysis of the GHQ-12: can I see that again? Aust NZ J Psychiat. 2003;37(4):475–83.CrossRef
28.
Navarro P, Ascaso C, Garcia-Esteve L, Aguado J, Torres A, Martin-Santos R. Postnatal psychiatric morbidity: a validation study of the GHQ-12 and the EPDS as screening tools. Gen Hosp Psychiat. 2007;29(1):1–7.CrossRef
29.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat. 1998;59(20):22–33. quiz 34–57.
30.
Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiat. 2000;157(5):816–8.CrossRefPubMed
31.
St Sauver JL, Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Early life risk factors for attention-deficit/hyperactivity disorder: a population-based cohort study. Mayo Clin Proc. 2004;79(9):1124–31.CrossRefPubMed
32.
Hair JFJ, Anderson RE, Tatham RL, Black WC. Multivariate data analysis. 3rd ed. New York: Macmillan; 1995.
33.
R Development Core Team. R. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2008.
34.
McLoughlin G, Ronald A, Kuntsi J, Asherson P, Plomin R. Genetic support for the dual nature of attention deficit hyperactivity disorder: substantial genetic overlap between the inattentive and hyperactive-impulsive components. J Abnorm Child Psych. 2007;35(6):999–1008.CrossRef
35.
36.
Gonzalez R, Schuster RM, Mermelstein RJ, Vassileva J, Martin EM, Diviak KR. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsyc. 2012;34(9):962–76.CrossRef
37.
Balodis IM, Potenza MN, Olmstead MC. Binge drinking in undergraduates: relationships with sex, drinking behaviors, impulsivity, and the perceived effects of alcohol. Behav Pharmacol. 2009;20(5–6):518–26.PubMedCentralCrossRefPubMed
38.
Krueger RF, Markon KE, Patrick CJ, Benning SD, Kramer MD. Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum. J Abnorm Psychol. 2007;116(4):645–66.PubMedCentralCrossRefPubMed
39.
Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ. Family transmission and heritability of externalizing disorders: a twin-family study. Arch Gen Psychiat. 2004;61(9):922–8.CrossRefPubMed
40.
Thapar A, Langley K, O’Donovan M, Owen M. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol Psychiatr. 2006;11(8):714–20.CrossRef
41.
Edwards AC, Kendler KS. Twin Study of the relationship between adolescent attention-deficit/hyperactivity disorder and adult alcohol dependence. J Stud Alcohol Drugs. 2012;73(2):185–94.PubMedCentralCrossRefPubMed
42.
von Stumm S, Deary IJ, Kivimaki M, Jokela M, Clark H, Batty GD. Childhood behavior problems and health at midlife: 35-year follow-up of a Scottish birth cohort. J Child Psychol Psyc. 2011;52(9):992–1001.CrossRef
43.
Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiat. 2007;64(10):1145–52.CrossRefPubMed
44.
Molina BS, Pelham WE, Gnagy EM, Thompson AL, Marshal MP. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res. 2007;31(4):643–54.PubMedCentralPubMed
45.
Dovis S, Van der Oord S, Huizenga HM, Wiers RW, Prins PJ. Prevalence and diagnostic validity of motivational impairments and deficits in visuospatial short-term memory and working memory in ADHD subtypes. Eur Child Adoles Psy. 2015;24(5):575–90.CrossRef
46.
Fredriksen M, Dahl AA, Martinsen EW, Klungsoyr O, Faraone SV, Peleikis DE. Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Atten Defic Hyperact Disord. 2014;6(2):87–99.PubMedCentralCrossRefPubMed
47.
Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatr. 2001;6(4):429–33.CrossRef
48.
Chung T, Ferrell R, Clark DB. Indirect association of DAT1 genotype with executive function through white matter volume in orbitofrontal cortex. Psychiat Res. 2015;232(1):76–83.CrossRef
49.
Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, et al. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacol. 2013;38(3):414–22.CrossRef
50.
Pingault JB, Cote SM, Galera C, Genolini C, Falissard B, Vitaro F, et al. Childhood trajectories of inattention, hyperactivity and oppositional behaviors and prediction of substance abuse/dependence: a 15-year longitudinal population-based study. Mol Psychiatry. 2013;18(7):806–12.PubMedCentralCrossRefPubMed
51.
Gibbins C, Weiss M. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep. 2007;9(5):420–6.CrossRefPubMed
52.
Rockett IR, Putnam SL, Jia H, Smith GS. Declared and undeclared substance use among emergency department patients: a population-based study. Addiction. 2006;101(5):706–12.CrossRefPubMed
53.
Konstenius M, Jayaram-Lindstrom N, Guterstam J, Beck O, Philips B, Franck J. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction. 2014;109(3):440–9.PubMedCentralCrossRefPubMed
54.
Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328–41.PubMedCentralCrossRefPubMed
55.
Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiat. 2000;157(7):1156–9.CrossRefPubMed
56.
Kraus L, Augustin R. Measuring alcohol consumption and alcohol-related problems: comparison of responses from self-administered questionnaires and telephone interviews. Addiction. 2001;96(3):459–71.CrossRefPubMed
57.
Feveile H, Olsen O, Hogh A. A randomized trial of mailed questionnaires versus telephone interviews: response patterns in a survey. BMC Med Res Methodol. 2007;7:27.PubMedCentralCrossRefPubMed
58.
Goldberg M, Chastang JF, Leclerc A, Zins M, Bonenfant S, Bugel I, et al. Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: A prospective study of the french GAZEL cohort and its target population. Am J Epidemiol. 2001;154(4):373–84.CrossRefPubMed
59.
Ramsay JR, Rostain AL. Adult ADHD research current status and future directions. J Atten Disord. 2008;11(6):624–7.CrossRefPubMed
60.
Hayaki J, Hagerty CE, Herman DS, de Dios MA, Anderson BJ, Stein MD. Expectancies and marijuana use frequency and severity among young females. Addict Behav. 2010;35(11):995–1000.PubMedCentralCrossRefPubMed
Metadata
Title
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey
Authors
Nathan J. Kolla
Mark van der Maas
Maggie E. Toplak
Patricia G. Erickson
Robert E. Mann
Jane Seeley
Evelyn Vingilis
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0746-4

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue

Study protocol

Infant sleep hygiene counseling (sleep trial): protocol of a randomized controlled trial

Research article

Adaptation of the Quality Indicator for Rehabilitative Care (QuIRC) for use in mental health supported accommodation services (QuIRC-SA)

Research article

Ontological security and connectivity provided by pets: a study in the self-management of the everyday lives of people diagnosed with a long-term mental health condition

Study protocol

Association between motor timing and treatment outcomes in patients with alcohol and/or cocaine use disorder in a rehabilitation program

Research article

Crime and victimisation in people with intellectual disability: a case linkage study

Research article

Development of a measure of model fidelity for mental health Crisis Resolution Teams